Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor

被引:514
作者
Bullock, BP [1 ]
Heller, RS [1 ]
Habener, JF [1 ]
机构
[1] HARVARD UNIV, HOWARD HUGHES MED INST,MASSACHUSETTS GEN HOSP, SCH MED,LAB MOL ENDOCRINOL, BOSTON, MA 02114 USA
关键词
D O I
10.1210/en.137.7.2968
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The incretin hormone glucagon-like peptide-1 (GLP-1) is an important regulator of postprandial insulin secretion. In addition to its insulinotropic actions on pancreatic beta-cells, GLP-1 enhances glucose disposal by insulin-independent mechanisms, suggesting that GLP-1 receptors are located on extrapancreatic tissues. In this study, we examined the tissue distribution of GLP-1 receptor (GLP-1R) messenger RNA (mRNA) in rat by RNAse protection, RT-PCR, and in situ hybridization. We identified GLP-1R mRNA in the lung, pancreatic islets, stomach, and kidney by the RNAse protection assay. RT-PCR analysis also detected GLP-1R mRNA in the hypothalamus and heart. In situ hybridization experiments identified receptor mRNA in the gastric pits of the stomach, large nucleated cells in the lung, crypts of the duodenum, and pancreatic islets. No localized specific grains were found in kidney, skeletal muscle, heart, liver, or adipocytes. These results indicate that sequences corresponding to the cloned rat islet GLP-1 receptor are expressed in the pancreatic islets, lung, hypothalamus, stomach, heart, and kidney but not in adipose, liver, and skeletal muscle. Further, the GLP-1 receptor expressed in the kidney and heart may be structural variants of the known receptor. Therefore, the observed extrapancreatic actions of GLP-1 may not be strictly confined to interactions with the defined GLP-1 receptor.
引用
收藏
页码:2968 / 2978
页数:11
相关论文
共 63 条
[1]   DISTRIBUTION OF NEUROTENSIN NEUROMEDIN-N MESSENGER-RNA IN RAT FOREBRAIN - UNEXPECTED ABUNDANCE IN HIPPOCAMPUS AND SUBICULUM [J].
ALEXANDER, MJ ;
MILLER, MA ;
DORSA, DM ;
BULLOCK, BP ;
MELLONI, RH ;
DOBNER, PR ;
LEEMAN, SE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (13) :5202-5206
[2]   GLUCAGON-LIKE PEPTIDE - A THERAPEUTIC GLIMMER [J].
AMIEL, SA .
LANCET, 1994, 343 (8888) :4-5
[3]   REDUCED CAPACITY AND AFFINITY OF SKELETAL-MUSCLE FOR INSULIN-MEDIATED GLUCOSE-UPTAKE IN NONINSULIN-DEPENDENT DIABETIC SUBJECTS - EFFECTS OF INSULIN THERAPY [J].
BARON, AD ;
LAAKSO, M ;
BRECHTEL, G ;
EDELMAN, SV .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (04) :1186-1194
[4]   ARTERIAL BLOOD-PRESSURE AND HEART-RATE INDUCED BY GLUCAGON-LIKE PEPTIDE-1-(7-36) AMIDE IN RATS [J].
BARRAGAN, JM ;
RODRIGUEZ, RE ;
BLAZQUEZ, E .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (03) :E459-E466
[5]   ABSENCE OF INSULINOTROPIC GLUCAGONLIKE PEPTIDE-I(7-37) RECEPTORS ON ISOLATED RAT-LIVER HEPATOCYTES [J].
BLACKMORE, PF ;
MOJSOV, S ;
EXTON, JH ;
HABENER, JF .
FEBS LETTERS, 1991, 283 (01) :7-10
[6]   SYNERGISTIC INDUCTION OF NEUROTENSIN GENE-TRANSCRIPTION IN PC12 CELLS PARALLELS CHANGES IN AP-1 ACTIVITY [J].
BULLOCK, BP ;
MCNEIL, GP ;
DOBNER, PR .
MOLECULAR BRAIN RESEARCH, 1994, 27 (02) :232-242
[7]   DIVERGENT TISSUE-SPECIFIC AND DEVELOPMENTAL EXPRESSION OF RECEPTORS FOR GLUCAGON AND GLUCAGON-LIKE PEPTIDE-1 IN THE MOUSE [J].
CAMPOS, RV ;
LEE, YC ;
DRUCKER, DJ .
ENDOCRINOLOGY, 1994, 134 (05) :2156-2164
[8]   GLUCAGON-LIKE PEPTIDE-1 ENHANCES GLUCOSE-TOLERANCE BOTH BY STIMULATION OF INSULIN RELEASE AND BY INCREASING INSULIN-INDEPENDENT GLUCOSE DISPOSAL [J].
DALESSIO, DA ;
KAHN, SE ;
LEUSNER, CR ;
ENSINCK, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :2263-2266
[9]   ENTERAL ENHANCEMENT OF GLUCOSE DISPOSITION BY BOTH INSULIN-DEPENDENT AND INSULIN-INDEPENDENT PROCESSES - A PHYSIOLOGICAL-ROLE OF GLUCAGON-LIKE PEPTIDE-I [J].
DALESSIO, DA ;
PRIGEON, RL ;
ENSINCK, JW .
DIABETES, 1995, 44 (12) :1433-1437
[10]   EFFECTS OF INSULIN ON PERIPHERAL AND SPLANCHNIC GLUCOSE-METABOLISM IN NONINSULIN-DEPENDENT (TYPE-II) DIABETES-MELLITUS [J].
DEFRONZO, RA ;
GUNNARSSON, R ;
BJORKMAN, O ;
OLSSON, M ;
WAHREN, J .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (01) :149-155